The Yield Enhancing Solution allows for higher collection volumes at each donation by stopping the collection process when plasma volume is reached, unlike traditional methods that stop system procedure when collection volume is reached. This translates into more plasma, more productivity, more value.
Higher Quality & Compliance: Automated procedure programming is designed to help avoid overdraws and underdraws, minimizing exceptions and protecting donor safety.
Strengthening Donor Relationships: Streamlined processes from setup and troubleshooting to disconnect. This minimizes wait times, helping ensure donor satisfaction and retention.
“The new technology implemented by Life Plasma increases plasma yield per donation by 18-26 mL in comparison to our industry peers with shorter collection time benefiting both patients and donors respectively” said Nagesh Ramesh, Ph.D., Founder and President, Life Plasma
To learn more about the Life Plasma center’s donation process, please visit: www.lifeplasma.com, or visit in person at 5438 Perkiomen Ave, Reading PA 19606.
About Life Plasma
Life Plasma is an FDA-licensed company specializing in the collection of human plasma used to make plasma-derived medicines for immune disorders, hemophilia, and critical care patients. Managed by a team of experts who have experience in the specialized field of plasma collection. Life Plasma centers follow FDA regulations and guidance and follow cGMP (current good manufacturing practices) in all their facilities. For more information about Life Plasma, please visit www.lifeplasma.com.
